Central regions | Technology & innovation | Finance, business

Skolkovo and AstraZeneca launch medtech start-up acceleration

16 May '19
Russias Skolkovo Foundation and AstraZeneca, a global biopharmaceutical company, are putting together a new joint acceleration program for projects that develop solutions for cancer therapy, cardiovascular diseases, metabolism and kidney problems, and respiratory diseases, Firrma.ru reported.

Primer Capital, a Russian venture fund with international presence, is acting as partner for the acceleration initiative.

The program will be aimed at identifying promising ideas and solutions to benefit the above-mentioned medical fields and also at addressing a range of specific problems in the existing healthcare system. Developing and promoting digital medicine solutions is also a goal for this years acceleration program.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations:

Latest News: Central regions
14 Feb '20 | Technology & innovation
14 Feb '20 | Finance, business | Telecoms, media
12 Feb '20 | Technology & innovation
12 Feb '20 | Finance, business | Real estate
 

Feature stories

25 Dec '19
Scientists in Siberia have come up with their own...
8 Nov '19
For the first time in the history of Russian-African...
29 Oct '19
Search (News archive - 21778)
Advertising
AIM_Congress
Advertising
NATT
Advertising
Venture_Russia_2018
Advertising
Marchmont News

Latest News

14 Feb '20
MTS, one of Russias top four mobile telecom...
12 Feb '20
A start-up called Tango Vision is developing a...
11 Feb '20
A Russian company is using technology to help high...

Most read stories from last week